Concepedia

Massimo Cristofanilli

MC

352

Publications

49.9K

Citations

99

H-Index

1998

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Northwestern University

Fox Chase Cancer Center

Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Thomas Jefferson University

Massimo Cristofanilli is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, breast cancer, and oncology.

ORCID

Top concepts

Publications per year

1998–2025

352

Publications

352

Circulating Tumor Cells, Disease Progression, and Survival in Metastatic Breast Cancer

Massimo Cristofanilli, G. Thomas Budd, Matthew J. Ellis et al. · New England Journal of Medicine · 2004 · 4.5K citations · Full text

Response to Neoadjuvant Therapy and Long-Term Survival in Patients With Triple-Negative Breast Cancer

Cornelia Liedtke, Chafika Mazouni, Kenneth R. Hess et al. · Journal of Clinical Oncology · 2008 · 2.9K citations · Full text

Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy

Roman Rouzier, Charles M. Perou, W. Fraser Symmans et al. · Clinical Cancer Research · 2005 · 1.9K citations · Full text

Fulvestrant plus palbociclib versus fulvestrant plus placebo for treatment of hormone-receptor-positive, HER2-negative metastatic breast cancer that progressed on previous endocrine therapy (PALOMA-3): final analysis of the multicentre, double-blind, phase 3 randomised controlled trial

Massimo Cristofanilli, Nicholas C. Turner, Igor Bondarenko et al. · The Lancet Oncology · 2016 · 1.8K citations

, , +12

Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer

Nicholas C. Turner, Jungsil Ro, Fabrice André et al. · New England Journal of Medicine · 2015 · 1.5K citations · Full text

Rows per page

1–5 of 352